← Leaderboards
Michael Xiang
Harvard Medical School
$67,392
Attributed
$67,392
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $33.7K · FY2012–13$50K$37.5K$25K$12.5K$0
'12
'13
Funding mix
By agency
NIH$67,392 · 1
By mechanism
F30$67,392 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard Medical School
Same institution · by research overlap
- Jeremy Purvis$5,214,387
- Jeremy Gunawardena$5,750,327
- Constance L Cepko$19,977,994
- Tyshia Kyree Gwin$100,819
- Michaela Ulrike Gack$22,395,027
Others in their field
Top investigators on “Antineoplastic Agents”
- David Heimbrook · Leidos Biomedical Research, Inc.$245,409,738
- Leonard Freedman · Leidos Biomedical Research, Inc.$243,278,693
- Gregory H Reaman · National Childhood Cancer Foundation$94,722,934
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,166,869
- Walter John Curran · Thomas Jefferson University$55,187,978
- Leonard Freedmand · Leidos Biomedical Research, Inc.$54,796,285
Research focus
Antineoplastic AgentsApoptosisBcl2 GeneBinding (Molecular Function)Binding SitesBiologyCancer BiologyCancer CellCancer Cell LineCancerousCell BehaviorCell CycleCell LineCell PhysiologyCellsClinicCodeComprehensionCyclin D1CytokineDimensionsDna SequenceEpigenetic ProcessAngiogenesis